Op. Dr. Alparslan Demir · Obstetrics and Gynaecology · Şişli, Istanbul
People with an HPV 70 positive result may find conflicting risk labels online. IARC places HPV 70 in Group 2B. This scientific classification is not a cancer diagnosis and does not prescribe the same follow-up procedure for everyone.
Why do some sources call HPV 70 low-risk?
Classifications can differ with publication date, research purpose and the laboratory panel. Older epidemiological groupings and IARC’s assessment of carcinogenic evidence do not necessarily use categories in the same way. For HPV 70, specifying IARC Group 2B makes the evidence framework clear. An isolated low-risk or high-risk label on a website cannot replace interpretation of your complete report.
Does Group 2B mean that cancer is suspected in me?
No. It describes evidence concerning a viral type; it is not a pathology finding diagnosing cancer in an individual. Detecting HPV 70 and finding abnormal cervical cells are different observations. A personal cancer probability cannot be calculated from this result alone. Pap findings, examination, concurrent HPV types and previous cervical disease are important context.
What if HPV 70 is positive but the Pap result is normal?
A normal Pap result means that no relevant abnormality was reported in the examined cells. That is useful information, but it should not be separated from the rest of the history. A fixed review interval or automatic colposcopy recommendation cannot responsibly be assigned from the HPV 70 number alone. Prior CIN or LEEP, abnormal cytology and suspicious lesions may require different assessment.
How does the test panel affect interpretation?
Not every HPV assay tests for HPV 70. If it is absent from a report, establish whether it was negative or simply outside the panel. A broad genotyping result may therefore not be directly comparable with a routine screening test. Compare sampling site, method and dates. Where a grouped result is reported, check whether an individual type was actually identified.
Is there vaccination or specific treatment for HPV 70?
HPV 70 is not directly covered by the nine-valent vaccine. Vaccination does not treat established positivity, although protection against other types may be worth discussing. A detected lesion requires its own diagnostic and management assessment. Bring complete HPV and cytology reports to a review so that decisions are based on findings rather than an alarming or reassuring label alone.
Review your HPV result in Şişli, Istanbul
For an individual review, bring your complete HPV, Pap and previous biopsy reports to an appointment with Dr Alparslan Demir.
Medical sources
- IARC — Scientific Council report (2024), HPV classifications, p. 2
- IARC Monographs — Human Papillomaviruses
- NCI — HPV and Cancer
- CDC — HPV Vaccination
Sources checked: 17 October 2026. This guide provides general information; an individual management plan requires clinical assessment.